Evaluation of Inflammatory Cytokines During COVID-19

University of Vienna100 enrolled

Overview

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted in the context of clinical parameters.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Covid19

Interventions

Blood sampleDIAGNOSTIC_TEST

Blood samples at different timepoints during SARS-CoV2 infection

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years * Confirmation of acute SARS-CoV2 infection * Ability to provide informed consent

Locations (1)

Medical University of Vienna

Vienna, Austria

RECRUITING

Outcomes

Primary Outcomes

Cytokine level in context with clinical parameters

Time frame: 2 weeks

Central Contacts

Daniela Gompelmann

CONTACT

0043 1 40400 47730 daniela.gompelmann@meduniwien.ac.at

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.